跳至主要内容
临床试验/NCT02071511
NCT02071511终止不适用

Renal Denervation In Patient Undergoing VT Ablation:Combined Renal Denervation and VT Ablation vs. Simply VT Ablation

Universitätsklinikum Hamburg-Eppendorf2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
50
试验地点
2
主要终点
Number of Patients with adverse events such as recurrens of Ventricular Tachycardias or necessary Intracardiac shocks during 24 months follow up

研究概览

简要总结

Study hypothesis:

With optimal medical therapy and repeated ablations, an additional renal denervation may have protective effects in terms of vegetative intrinsic activity and lead to a significant reduction in VT Burdens.

Study design:

Multicenter, randomized, prospective, single-blind clinical trial.

详细描述

Study protocol:

Catheter ablation of ventricular tachycardia versus combined catheter ablation of ventricular tachycardia and renal denervation.

A total of 50 patients with ventricular tachycardia treated with ICD shocks or ATP will be enrolled in this study. The randomization in the study is done before ablation.

For the ablation, an arterial access is required in both groups. During a 30 minutes waiting time which will apply to both groups, renal denervation will be performed.

In this period of time operators and staff will be blinded for the procedure, thereby they won't know if the patients will receive a renal denervation, in that way the investigators are avoiding a bias of future treatment of the patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Ischemic cardiomyopathy
  • NYHA II-III
  • Recurrent ventricular tachycardia, ICD interventions (shock or ATP)
  • Obtained written informed consent

排除标准

  • Age <18 years
  • Previous VT ablation
  • Cardiopulmonary decompensation within the last 4 weeks
  • Pregnant women or women of childbearing potential without a negative pregnancy test within 48 hours prior to treatment
  • History of hemorrhagic diathesis or other coagulopathies
  • Contraindication for oral anticoagulation
  • Hyper- or hypothyroidism
  • Drug or chronic alcohol abuse
  • Has any condition that would make participation not be in the best interest of the subject
  • Incompliance

结局指标

主要结局

Number of Patients with adverse events such as recurrens of Ventricular Tachycardias or necessary Intracardiac shocks during 24 months follow up

时间窗: 24 months

Number of Patients with adverse events such as recurrens of Ventricular

次要结局

  • Number of Patients with Ventricular extrasystoles and non-sustained Ventricular Tachycardias compared to the time prior to ablation during 24 months follow up(24 months)
  • Number of periprocedural complications(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验